Chat with us
Research Assistance
Online
  • Please enter your first name.

Italy Immunosuppressant Drugs Market, 2020-2027

The immunosuppressant drugs market in Italy is expected to reach a projected revenue of US$ 3,520.7 million by 2027. A compound annual growth rate of 6.2% is expected of Italy immunosuppressant drugs market from 2021 to 2027.

  • Pharmaceuticals
    • Metabolic Disorders Treatment
      • Immunosuppressant Drugs Market
Revenue, 2020 (US$M)
$2,309.9
Forecast, 2027 (US$M)
$3,520.7
CAGR, 2021 - 2027
6.2%
Report Coverage
Italy

Italy Immunosuppressant Drugs Market, 2016-2027 (US$M)

Italy Immunosuppressant Drugs Market, 2016-2027 (US$M)

This page contains premium content. Request sample data or start your free trial to explore Horizon.

  • ✔ Access to global market statistics
  • ✔ Access to company profiles
  • ✔ Free use-cases & research insights

No credit card required*

Prism AI by Grand View ResearchFree to try

Ask a question about the immunosuppressant drugs market

Every figure cited from GVR research

Italy immunosuppressant drugs market highlights

  • The Italy immunosuppressant drugs market generated a revenue of USD 2,309.9 million in 2020 and is expected to reach USD 3,520.7 million by 2027.
  • The Italy market is expected to grow at a CAGR of 6.2% from 2021 to 2027.
  • In terms of segment, monoclonal antibodies was the largest revenue generating drug class in 2020.
  • Monoclonal Antibodies is the most lucrative drug class segment registering the fastest growth during the forecast period.


Immunosuppressant drugs market data book summary

Market revenue in 2020USD 2,309.9 million
Market revenue in 2027USD 3,520.7 million
Growth rate6.2% (CAGR from 2020 to 2027)
Largest segmentMonoclonal antibodies
Fastest growing segmentMonoclonal Antibodies
Historical data2016 - 2019
Base year2020
Forecast period2021 - 2027
Quantitative unitsRevenue in USD million
Market segmentationCalcineurin Inhibitors, MTOR Inhibitors, Antiproliferative Agents, Monoclonal Antibodies


Other key industry trends

  • In terms of revenue, Italy accounted for 2.4% of the global immunosuppressant drugs market in 2020.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2027.
  • In Europe, Germany immunosuppressant drugs market is projected to lead the regional market in terms of revenue in 2027.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 10,167.1 million by 2027.

According to OECD data, Italy has the highest number of geriatric population after Japan. In the year 2019, 23.1% of the total population in Italy was estimated to be aged 65 years and above. These demographic trends impose numerous implications for the government and private sectors in the country.

According to NCBI, cavitated caries lesions, severe periodontitis were prevalent among 42.10% of the Italian population. In 2017, approximately 7.9% of the population suffered from periodontal disease in Italy. These factors are likely to propel the sealant and adhesive market growth in the country. The trend of cosmetic dentistry procedures is being rapidly adopted by Italian population, mainly due to their growing attention to their appearance.

Italians are sensitive to oral hygiene and considers it as an essential part of the overall care. However in Italy oral healthcare is mainly provided under private arrangements. The public healthcare system provides only 5–8% of oral healthcare services and this percentage varies from region to region.

No credit card required*

Customize the Report

20% free customization

Include
Countries, segments, points
Tailor
To your product definition
Extend
Deeper competitor detail
Or
A fully bespoke study

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Immunosuppressant Drugs Market Companies

NameProfile# EmployeesHQWebsite

Italy Immunosuppressant Drugs Market

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Immunosuppressant Drugs Market will help companies and investors design strategic landscapes.


Monoclonal Antibodies was the largest segment with a revenue share of 73.52% in 2020.

Horizon Databook has segmented the Italy immunosuppressant drugs market based on calcineurin inhibitors, mtor inhibitors, antiproliferative agents, monoclonal antibodies covering the revenue growth of each sub-segment from 2016 to 2027.




According to OECD data, Italy has the highest number of geriatric population after Japan. In the year 2019, 23.1% of the total population in Italy was estimated to be aged 65 years and above. These demographic trends impose numerous implications for the government and private sectors in the country.

According to NCBI, cavitated caries lesions, severe periodontitis were prevalent among 42.10% of the Italian population. In 2017, approximately 7.9% of the population suffered from periodontal disease in Italy. These factors are likely to propel the sealant and adhesive market growth in the country. The trend of cosmetic dentistry procedures is being rapidly adopted by Italian population, mainly due to their growing attention to their appearance.

Italians are sensitive to oral hygiene and considers it as an essential part of the overall care. However in Italy oral healthcare is mainly provided under private arrangements. The public healthcare system provides only 5–8% of oral healthcare services and this percentage varies from region to region.

  • Italy Immunosuppressant Drugs Market Drug Class Outlook (Revenue, USD Million , 2016-2027)
    • Calcineurin Inhibitors
    • mTOR Inhibitors
    • Antiproliferative Agents
    • Monoclonal Antibodies
    • Others
  • Italy Immunosuppressant Drugs Market Application Outlook (Revenue, USD Million , 2016-2027)
    • Autoimmune Diseases
    • Organ Transplants
    • Other Applications
  • Italy Immunosuppressant Drugs Market Route of Administration Outlook (Revenue, USD Million , 2016-2027)
    • Oral
    • Injectables
  • Italy Immunosuppressant Drugs Market Distribution Channel Outlook (Revenue, USD Million , 2016-2027)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Reasons to subscribe to Immunosuppressant Drugs Market databook

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Immunosuppressant Drugs Market databook

  • Our clientele includes a mix of Immunosuppressant Drugs Market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Italy Immunosuppressant Drugs Market, including forecasts for subscribers. This country databook contains high-level insights into Italy Immunosuppressant Drugs Market from 2016 to 2027, including revenue numbers, major trends, and company profiles.

Italy Immunosuppressant Drugs Market, 2016-2027 (US$M)

No Access Stack Chart

Italy immunosuppressant drugs market statistics, by drug class, 2016-2027 (US$M)

No Access Pie Chart

Italy immunosuppressant drugs market statistics, by drug class, 2016-2027 (USD Million)

No Access

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more